The University of Maryland spinout said it plans to launch a point-of-care urinary tract infection test by 2025, followed by three more tests by 2028.
Less than one quarter of pathology labs have adopted whole-slide imaging so far, but pathologists and companies in the space ...
The deal comes on the heels of a similar arrangement Nanostics struck with Protean BioDiagnostics for the US market.
According to the government, Rashid Naqvi, a Houston-area resident, fraudulently sought $4.6 million from Medicare for COVID-19 test kits and obtained $2.0 million.
The change applies to qualitative and quantitative hepatitis B virus antigen, antibody, and nucleic acid assays that are used to detect acute and chronic infections.
The tool uses two blood-based biomarkers and up to five clinical features to generate a risk score for prostate cancer aggressiveness.
NEW YORK – The Alzheimer's Drug Discovery Foundation on Wednesday announced that it has invested $7.0 million in Alzheimer's disease diagnostic company C2N Diagnostics. Already have a 360Dx or ...
Lab test reimbursement cuts and price reporting requirements that were called for under the law will be delayed as part of the recently passed spending bill.
Trinity plans to bring to market in 2025 Metabolomics Diagnostics' PrePsia test that can be used to determine preeclampsia risk in the 12th week of pregnancy.
The partnership will include collaborative research with a focus on expanding the use of in vitro diagnostics to support antimicrobial stewardship programs.
The national contract covers FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.
The agreement includes $650 million of 4.35 percent senior notes, $500 million of 4.55 percent senior notes, and $850 million of 4.8 percent senior notes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback